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Abstract
Background:  Primary Percutaneous Coronary Intervention (PCI) is more efficacious than
thrombolysis in the management of acute myocardial infarction, but, because of the requirement
for prompt treatment, there are practical challenges in developing such services. We examined the
proportion of patients with ST segment Elevation Myocardial Infarction (STEMI) who could receive
timely treatment from a primary Percutaneous Coronary Intervention (PCI) service assuming
different geographical locations of potential treatment centres in three English counties.
Methods and results: Information on the residential location of patients with new STEMI
hospitalisations recorded in Hospital Episodes Statistics was analysed and the proportion of
episodes of STEMI within 60' and 45' travel time isochrones from potential primary PCI centres in
three English counties was calculated. There were on average 1,815 new STEMI hospitalisations per
year occurring in the studied population. Introduction of a primary PCI service in one, two or three
potential treatment centres would have covered respectively 28%, 73% and 90% of such episodes
within 60 minutes travel time, and 17%, 51% and 69% within 45 minutes travel time.
Conclusion: In the study context, a primary PCI service in an existing tertiary centre would only
cover a minority of STEMI events and would generate geographical inequities. A two-centre model
would improve coverage and equity considerably, but may be associated with practical, clinical
quality and financial challenges.
Background
Although primary Percutaneous Coronary Intervention
(PCI) is more efficacious for the treatment of ST-segment
Elevation Myocardial Infarction (STEMI) compared with
thrombolysis, [1-6] the comparative advantage is highly
time dependent. The European Society of Cardiology
(ESC) currently recommends a limit of 90 minutes from
first medical contact to initiation of treatment [7,8] This
means that travel time considerations are of paramount
importance in accessing such a service, particularly so in
rural areas. The United Kingdom's Department of Health
has recently published a policy document, supporting the
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use of primary PCI for the management of STEMI [9] Nor-
folk, Suffolk and Cambridgeshire are three predominantly
rural English counties, with a mid-2004 resident popula-
tion estimate of 2.24 million, living in an area of approx-
imately 4,850 square miles. At the time of the study,
management of STEMI with primary PCI was not rou-
tinely used in the three counties. Given the spatial distri-
bution of STEMIs relative to potential treatment centres,
we set out to determine the incremental coverage of one,




It was assumed that in order to administer the treatment
within existing guideline times of 90 minutes, [7,8,10,11]
there is a maximum period of 60 minutes available to
transport a patient from the place of STEMI onset to a pri-
mary PCI centre. This assumes that the time required for
transporting the patient in and out of the ambulance, and
from arrival at the hospital door to first balloon inflation
(door-to-balloon time) is less than 30 minutes. In supple-
mentary analysis, an additional period of 15 minutes was
allowed for transporting the patient in and out of the
ambulance, and for door-to-balloon time, therefore
reducing the time available for travel from the place of
onset to the hospital door to a maximum of 45 minutes.
Geographical analysis
New STEMI-related hospitalisations [defined as Hospital
Episode Statistics (HES) records with an ICD-10 primary
diagnosis code of I210, I211, I212, I220, I221 or I228,
and no record of a previous STEMI hospitalisation within
the 28 days prior to admission] in patients aged 18 and
over were analysed for the five-year period 1998–99 to
2002–03. Hospital Episodes Statistics do not record the
location of STEMI onset (and ambulance pick-up), and
obtaining such information was not possible within the
resources available. Therefore, the patient's post-code of
residence was used as a surrogate marker of STEMI onset
location. This assumes that STEMI onset location outside
the patients' own home was, on average, randomly scat-
tered around their residential post-code, both in terms of
distance and travel time to potential treatment centres.
Subsequently, all new STEMI episodes recorded in HES
were mapped to the respective patient postcodes using
Geographical Information System (GIS) software (ArcGIS
version 9). The shortest route to potential primary PCI
centres was identified and the weighted average mean
travel time to each potential primary PCI centre was calcu-
lated assuming 'blue light' ambulance travel speeds
through the routes identified.
Choice of one-, two- and three-centre potential locations
The potential primary PCI centres examined in this study
represent the location of an existing tertiary cardiac centre
(one-centre scenario), or the location of an existing teach-
ing hospital in addition to the cardiac centre (two-centre
scenario). The third location, in the three-centre scenario,
relates to an existing District General Hospital. It was cho-
sen from a total of another six hospitals of a similar type,
compared with the two-centre scenario, as it provided the
relatively greatest gain in coverage
Coverage estimates
STEMI events relating to patients whose residence was
within the travel time limits to a potential primary PCI
centre were assumed to have had access to primary PCI.
The incremental coverage for one-centre, two centre and
three-centre scenarios were calculated using SPSS version
11.5.
Results
During the five-year study period, there were on average
1,815 new STEMI hospitalisations per year in Norfolk Suf-
folk and Cambridgeshire residents in National Health
Service (NHS) hospitals within these three counties,
recorded in the HES dataset.
The coverage of all new STEMI hospitalisation for one,
two and three potential primary PCI centres is described
in table 1. The coverage increased from 28% and 17% for
an one-centre model alone to 73% and 51% for the two-
centre and 90% and 69% for the three-centre models,
using the 60 and 45 minute travel time limits respectively
(see figures 1, 2 and 3).
Discussion
In the study setting and using the European Society of Car-
diology Guidelines about target time for administration
of primary PCI, introduction of a PCI service for the man-
agement of STEMI in a single centre (one-centre location)
will be associated with substantial geographical inequity.
A two-centre provision greatly improves geographical cov-
Table 1: Coverage of STEMI events by the provision of primary PCI using one, two or three-centre models.
Model of provision Coverage at 60 minutes, % (95% CI) Coverage at 45 minutes, % (95% CI)
One centre 28.4 (27.5–29.3) 16.5 (15.8–17.2)
Two centre 73.4 (72.5–74.3) 51.3 (50.3–52.3)
Three centre 89.8 (89.2–90.4) 69.0 (68.1–69.9)International Journal of Health Geographics 2007, 6:43 http://www.ij-healthgeographics.com/content/6/1/43
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erage and a three-centre option raises coverage further.
However, the latter two scenarios may be associated with
very important resource implications, staffing and clinical
quality challenges.
This study used an innovative methodology to estimate
the proportion of STEMI events that can benefit from a
primary PCI service in three counties of a European coun-
try. It used five years of event data and estimated propor-
tional coverage for potential primary PCI centres taking
into account shortest travel route to a potential centre,
assuming blue light ambulance travel speeds. Using geo-
graphical analysis to estimate proportional coverage for a
primary PCI service development can usefully underpin
and facilitate the planning, development and monitoring
of such healthcare services.
Although the application of the methodology relates to
one distinct geographical area, it can easily be extended to
other areas, and indeed also applied to different health-
care services if mean travel time considerations are of rel-
evance to policy-making.
Our study used actual event data, over a five-year period.
We believe that this is superior to calculations based on
general population density alone – as the latter may not
GIS mapping of all new STEMI patients (1998–99 to 2002–03) across Norfolk Suffolk and Cambridgeshire within 60 minutes  isochrones of travel times (blue light ambulance) from centre one Figure 1
GIS mapping of all new STEMI patients (1998–99 to 2002–03) across Norfolk Suffolk and Cambridgeshire within 60 minutes 
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correlate highly with coronary heart disease burden, due
to the uneven spatial distribution of demographic param-
eters, such as age and social deprivation. Clearly, a propor-
tion of patients developing a STEMI event will not be
eligible for primary PCI, on account of medical reasons.
However, this consideration is independent of the geo-
graphical location, and the percentage coverage estimates
presented here apply to those patients eligible for primary
PCI.
There are certain limitations of our study. Firstly, we used
the post-code of residence of patients who suffered from a
STEMI event that resulted in hospitalisation as a surrogate
marker for event location. The onset of some STEMI
events will take place outside the patients' residence, e.g.
in the community. However, overall, this is unlikely to
have introduced differential bias in relation to travel time
to a potential PCI centre. We assumed that the distribu-
tion of travel times from the home addresses of patients
admitted with STEMIs provided an unbiased estimate of
the distribution of travel times from the actual site of
onset – in other words that the instances when the actual
site of onset was further from the treatment centre of inter-
est would be approximately offset by the instances when
it was closer.
GIS mapping of all new STEMI patients (1998–99 to 2002–03) across Norfolk Suffolk and Cambridgeshire within 60 minutes  isochrones of travel times (blue light ambulance) from centre two Figure 2
GIS mapping of all new STEMI patients (1998–99 to 2002–03) across Norfolk Suffolk and Cambridgeshire within 60 minutes 
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Secondly, we have treated the three counties of Norfolk,
Suffolk & Cambridgeshire as an 'island'. However, the ter-
tiary centre relating to the one-centre option provides car-
diothoracic services not only to the three counties
examined in this study, but also to at least another four
neighbouring counties. Our results therefore underesti-
mate the absolute population that could be served if such
a service was introduced. Nevertheless, this option will
certainly introduce significant inequity in care provided to
STEMI patients within the population of primary interest
to this study. As the number of tertiary cardiac centres is
unevenly distributed between English counties, future
work should address the question of optimal service con-
figuration for a potential primary PCI service develop-
ment at inter-regional and national level.
Conclusion
A primary PCI service in one existing tertiary centre would
only cover a minority of STEMI events and would generate
geographical inequities. A two-centre option improves
access greatly. However, setting up a primary PCI service
in a centre where one doesn't exists requires significant
capital expenditure to expand facilities and recruit, train
and employ relevant staff. In addition, there may be chal-
lenges in maintaining clinical quality in hospitals with a
relative low throughput of patients. If newer evidence
GIS mapping of all new STEMI patients (1998–99 to 2002–03) across Norfolk Suffolk and Cambridgeshire within 60 minutes  isochrones of travel times (blue light ambulance) from centre three Figure 3
GIS mapping of all new STEMI patients (1998–99 to 2002–03) across Norfolk Suffolk and Cambridgeshire within 60 minutes 
isochrones of travel times (blue light ambulance) from centre three.Publish with BioMed Central    and   every 
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would indicate that certain PCI treatment protocols may
be superior to thrombolysis beyond the time period from
symptom onset currently recommended, [12] assump-
tions about time periods modelled should be likewise
informed in subsequent analyses.
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